James Joseph Caruso - Jan 9, 2023 Form 4 Insider Report for Ra Medical Systems, Inc. (RMED)

Role
Director
Signature
/s/ Will McGuire, as Attorney-in-Fact
Stock symbol
RMED
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
4
Date filed
1/11/2023, 04:17 PM
Next filing
Mar 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMED Series X Convertible Preferred Stock Award +9.71 9.71 Jan 9, 2023 Common Stock 9.71K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.
F2 On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).
F3 Series X Convertible Preferred Stock has no expiration date.